Interactions of Neuromodulators with Cells of the Immune System

Abstract

The research program is designed to explore the effects of norepinephrine (NE) and other neuromodulators on non-neuronal cells. During the past year significant progress has been made in four inter-related areas: 1) The effects of norepinephrine on mitogenstimulated spleen lymphocytes, thymocytes, nude mouse lymphocytes and Balb/c T cell lymphosarcoma cells (S49 cells) has been examined in a serum-free culture system. Norepinephrine has been shown to mediate inhibition of both T & B cell activation, probably through different mechanisms which may involve cyclic AMP in the T cell but not in the B cell. 2) NE also inhibits IL2 generated lymphocyte activation in serum-free culture, suggesting that the mechanisms of NE-mediated IL2 inhibition is distel to ConA binding and may also involve IL2 receptor regulation. 3) In contrast to its effects on immmune cells, NE mediates keratinocyte mitogenesis. 4) NE appears to down regulate the appearance of thyl protein on the surface of lymphocytes, thymocytes and keratinocytes. Parallel experiments with cAMP show a similar effect of cAMP-mediated thyl protein down regulation, suggesting that cAMP could be mechanistically involved with thyl gene expression.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 05, 1988
Accession Number
ADA198847

Entities

People

  • Donald A. Chambers

Organizations

  • University of Illinois at Chicago

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Anti-Bacterial Agents
  • B Lymphocytes
  • Biological Sciences
  • Blood
  • Cell Physiological Processes
  • Cells
  • Chemistry
  • Epithelial Cells
  • Health Services
  • Illinois
  • Immune System
  • Lymphatic System
  • Lymphocytes
  • Military Research
  • Nucleotides
  • Thymocytes
  • Tissues

Fields of Study

  • Biology
  • Medicine

Readers

  • Breast cancer cell signaling and growth regulation.
  • Cardiovascular Physiology
  • Geochemistry

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech